A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer

NCT06111274 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: Pimicotinib (ABSK021)

Sponsor

Abbisko Therapeutics Co, Ltd